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Summary
Objective: This study was undertaken in order to study the expression of type VI collagen in normal and osteoarthritic
human knee cartilage.
Methods: Seventy-two osteoarthritic cartilage/bone samples were obtained form 29 patients with primary OA
undergoing surgery for a total knee replacement. Normal cartilage was collected from five human knees at the time of
autopsy. Type VI collagen protein was localized using a polyclonal anti human type VI collagen antibody, the
corresponding mRNA was detected with an 310 base antisense probe, specific for the Æ2(VI) collagen chain.
Results: In normal cartilage, type VI collagen protein is concentrated pericellularly around the chondrocytes of all
cartilage zones. In the middle and deep zones, type VI collagen was also found in the interterritorial matrix. Type VI
collagen mRNA expression was detected in chondrocytes of all cartilage zones. In moderately a#ected osteoarthritic
cartilage, type VI collagen expression was increased. An intensive immunohistological interterritorial staining for
type VI collagen was observed in the middle and deep cartilage zones. Specific mRNA signals were also increased
especially in the middle and deep cartilage zone. In the superficial zone and calcified cartilage of these samples, type
VI collagen mRNA expression was restricted to focal areas. In severe osteoarthritic cartilage, an intensive staining for
type VI collagen mRNA was found in clusters of proliferating chondrocytes and in the deep cartilage zone. Type VI
collagen was localized pericellularly and in the matrix of chondrocyte clusters. Furthermore, chondrocytes from the
deep zone showed a territorial distribution of type VI collagen.
Conclusions: These results demonstrate that in normal and osteoarthritic cartilage, type VI collagen is expressed in
a zone specific pattern. The observed increase of type VI collagen expression in osteoarthritis suggests a potential role
in the disease process.
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A BALANCED metabolism of the various extracellu-
lar matrix components is necessary to maintain
the structure und function of articular cartilage.
During the process of osteoarthritis (OA),
metabolic alterations lead to a finally irreversible
loss of the cartilage matrix. Articular cartilage is
a highly organized tissue consisting of specific
proteoglycans filling the network of collagen fibres
which contains type II collagen as major and types
IX and XI as minor collagens [1]. Early immuno-
histological studies by Ayad et al. [2] suggested
that hyaline cartilage also contains type VI col-
lagen. Quantitatively, type VI collagen belongs to191the minor collagens in cartilage with an approxi-
mate content of less then 2% of the total collagens
[3, 4]. The molecule forms a heterotrimer, consist-
ing of three genetically di#erent alpha chains
(Æ1(VI), Æ2(VI), Æ3(VI)). Type VI collagen mono-
mers are arranged as dimers and tetramers, which
form a separate collagenous network [5, 6]. On the
amino-terminal and carboxy-terminal ends, two
large globular domains are attached to the triple
helical domain of the molecule [5, 7]. The globular
domains show a variety of sequence homologies to
domains of other molecules like the Kunitz-type
protease inhibitor, the von Willebrand Factor
A domain, fibronectin type III, actin, salivary
proteins and other proteins [8, 9] and may be
responsible for specific functions of this collagen.
In-vitro experiments have shown that type VI col-
lagen has binding capacities to several matrix
molecules like type I collagen [10, 11], type II
collagen [12] and type XIV collagen [13] and also
to noncollagenous proteins like decorin [12, 14],
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[16]. Interactions of type VI collagen with the cell
surface are mediated by Æ1â1 integrins and Æ2â1
integrins [17, 18] and also by non-integrin medi-
ated binding mechanisms [19, 20]. Type VI collagen
is supposed to play an important role in the organ-
ization of the pericellular matrix and to anchor
chondrocytes in their surrounding extracellular
matrix [21]. In articular cartilage, chondrocytes of
the middle and deep cartilage layers are embedded
in a pericellular matrix with a high proteoglycan
[22] and hyaluronic acid content [23]. The peri-
cellular matrix is surrounded by a pericellular
capsule, which consists of fine fibrils forming a
basket-weave like network. Outside the pericellu-
lar capsule a zone of thicker fibrils and high
proteoglycan content forms the territorial matrix
[24].
Histomorphological and immunohistochemical
investigations have localized type VI collagen
fibrils in the pericellular matrix and capsule of the
chondrocytes [2, 21, 25, 26]. In the territorial
matrix, type VI collagen was detected as randomly
distributed deposits [27] and periodic fibrils [25].
Increased levels of type VI collagen were found
in experimental models of OA [27, 28] and in
human OA [4, 26]. It is still unclear whether
increased concentrations of type VI collagen in
cartilage are the result of a continuous deposition
of this molecule or also caused by an increased
synthesis. In addition, the topographical localiz-
ation of the protein and gene expression of type VI
collagen in the di#erent zones of normal and osteo-
arthritic cartilage are not yet known. The aim of
this study was to systematically characterize and
localize the type VI collagen expression in OA by
immunohistology and in-situ hybridization to get a
better understanding of the metabolic activation
of chondrocytes in osteoarthritic cartilage.Materials and methodsCARTILAGE SAMPLES
Seventy-two osteoarthritic cartilage/bone
samples were obtained form 29 patients with pri-
mary OA (54–75 year-old donors) undergoing sur-
gery for a total knee replacement. Clinical data
were carefully reviewed to exclude any forms of
secondary OA and inflammatory joint diseases
like rheumatoid arthritis. Normal cartilage was
collected from five human knees at the time of
autopsy within 18 h after death (34–56 year-old
donors). In normal cartilage samples, both the
tibia plateaus and femoral condyles were macro-
scopically normal without any signs of osteo-arthritis. The localizations, where the samples
were taken from, were carefully monitored by
video printouts. Osteoarthritc changes were
graded using the grading system of Otte [29]
(Table 1). There were five normal samples, 10
samples with slight, 27 samples with moderate, and
35 samples with severe osteoarthritic lesions.PREPARATION OF TISSUE SAMPLES
One-cm thick cartilage/bone samples with a
cartilage surface of about 2.0 cm#0.5 cm were
incubated in freshly prepared paraformaldehyde,
4% (w/v), bu#ered with 0.01 M sodium phosphate,
pH 7.4, containing 0.14 M NaCl (PBS) overnight at
4)C. The tissue samples were decalcified in diethyl-
pyrocarbonate (DEPC)-treated 0.2 M EDTA,
pH 8.0 for several weeks at 4)C. The bu#er was
changed twice per week. Tissue specimens were
then embedded in para$n. Cartilage/bone sections
(5 ìm) were mounted on glass slides, precoated
with 1% (v/v) 3-aminopropyl triethoxysilane and
heated for 90 min at 65)C.PREPARATION OF THE TYPE VI COLLAGEN RNA PROBES
Total RNA was extracted from human knee
cartilage. Cartilage (0.5 g) was frozen in liquid
nitrogen and pulverized using a stainless steel
pestle and mortar. Extraction was performed using
acid guanidinium isocyanate as described by
Chomczynski et al. [30]. One ìg of total RNA was
transcribed into single-stranded cDNA using AMV
reverse transcriptase (Boehringer Mannheim,
Mannheim, Germany) and Oligo-p(dT)15 as
primer according to the manufacturer’s protocol
(Boehringer Mannheim, Mannheim, Germany).
Double-stranded cDNA was generated by PCR
using modified primers containing a new HindIII
site in the upstream primer (5*-TCC AAG CTT
CAA AGG AGA GAA-3*), and a new EcoRI site in
the downstream primer (5*-GTC CTT AAG GAC
CCC GAG GTA A-3*). The primer pair spans 299
bases coding for the N-terminal area of the triple
helical domain of the Æ2(VI) collagen chain. The
PCR product as well as the cloning vector (pT3/
T7Æ18 Life Science, Eggenstein, Germany) were
digested with the restriction enzymes EcoRI and
HindIII. Following ligation, cloning and amplifi-
cation the plasmid DNA was checked by multiple
restriction digestions as well as by sequencing
(Perkin-Elmer, Abiprism, Weiterstadt, Germany).
For in-vitro transcription and labelling of anti-
sense and sense riboprobes, the plasmid DNA was
digested with HindIII for the antisense probe and
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chloroform extraction and transcribed using 1 ìg
of linearized plasmid DNA, 1 mM ATP, 1 mM
CTP, 1 mM GTP, 0.65 mM UTP and 0.35 mM
digoxigenin-11-UTP in 40 mM Tris-HCl, pH 8.0,
6 mM MgCl2, 10 mM dithiotritol, 2 mM spermidin
and 40 U T7 RNA-Polymerase (for the antisense
probe) or 40 U T3 RNA-Polymerase (Boehringer
Mannheim, Mannheim, Germany) for the sense
probe. The components were incubated for 2 h at
37)C. Template DNA was removed with 20 U
DNase I (Boehringer Mannheim, Mannheim,
Germany). The reaction was stopped by adding 2 ìl
0.2 M EDTA, pH 8.0. RNA was further purified by
ethanol precipitation and resuspended in 100 ìl
DEPC-treated H2O. Transcripts were checked for
integrity, length (310 bases) and labeling e$ciency
by denaturing gel electrophoreses followed by blot-
ting on nitrocellulose membrane and digoxigenin
detection using the DIG-nucleic-acid-detection-kit
(Boehringer Mannheim, Mannheim, Germany).
About 100 ng Æ2(VI) collagen antisense or sense
riboprobe were used for each tissue section.
Immediately before use, riboprobes were incu-
bated at 96)C for 10 min followed by 2 min
at 4)C. An Oligo-p(dT)28 primer, 5*-endlabeled
with digoxigenin-ddUTP (Biometra, Go¨ttingen,
Germany), which detects all polyadenylated
mRNAs, was used as a positive control.CONTROLS
The specificity of the type VI collagen probe was
checked by Northern blotting using placenta
mRNA as a target (data not shown). The probe was
specific for a mRNA of 3.5 kilobases corresponding
to the size of the Æ2(VI) collagen chain. In addition,
nucleic acid sequence homologies were tested
using the FASTA program at the EMBLE Institute
in Heidelberg, Germany. Homologies to the
Æ1(VI)-, Æ3(VI) chain, and to other known collagens
and proteins were less then 54%.
In order to exclude a chain specific increased
expression of the Æ2(VI)-chain mRNA, a riboprobe
against Æ3(VI) was generated using the cloning
strategy as described above (upstream primer: 5*-
GAG AAG CTTGAG GAC CTG GAG A -3*; down-
stream primer: 5*- CCA GGA ATT CCT CTT TCT
CCT T – 3*). The antisense Æ3(VI) riboprobe (388
bases) has a 99% homology to the triple helical
domain of the Æ3 chain of type VI collagen. Nucleic
acid analysis revealed less than 56% homology to
the Æ1(VI)-, Æ2(VI) chain, and to other known
human proteins. Two samples from normal carti-
lage and cartilage with early, moderate and severe
lesions were hybridized. Non-specific staining ofthe probes to DNA sequences was excluded by an
additional RNase treatment of the specimen prior
to in-situ hybridization. In all control samples in
which the RNA was predigested, no specific cellu-
lar staining was observed by in-situ hybridization
using the type VI collagen probe or the poly
dT-probe.IN-SITU HYBRIDIZATION
Tissue sections were de-para$nized in xylene
and rehydrated through graded ethanol (100–50%).
Sections were incubated with Proteinase K, 50 ìg/
ml in 100 mM Tris, pH 7.5, with 50 mM EDTA,
for 15 min at 37)C and postfixed in 4% (w/v)
paraformaldehyde/PBS for 1 min. Sections were
briefly washed in DEPC-treated double distilled
water and acetylated in 0.1 M triethanolamine by
adding 0.3% (v/v) acetic acid anhydride twice for
5 min. Sections were briefly incubated in PBS,
dehydrated in increasing concentrations of
ethanol (50–100%) and then air-dried under dust-
free conditions. Sections were prehybridized with
a commercial hybridization bu#er including 0.5 M
NaCl and blocking reagent (ECL gold hybridiz-
ation bu#er, ECL blocking reagent, Amersham,
Braunschweig, Germany). The bu#er contained
8 M urea, which is equivalent to 50% (v/v) forma-
mide to reduce the melting temperature of nucleic
acid hybrids. Sections were carefully covered
with a plastic film (Parafilm, Sigma, Mu¨nchen,
Germany) and prehybridization was carried out for
1 h at 43)C for Æ2(VI) collagen probe and at 37)C for
the poly dT-probe. For specific hybridization,
sections were incubated with 50 ìl hybridization
bu#er containing the Æ2(VI) or Æ3(VI) collagen
probe (2 ìg/ml) or the poly dT probe (1 ìg/ml).
Again, sections were covered with parafilm and
hybridization was carried out in a humidified
chamber at 43)C (Æ2(VI) collagen probe) or 37)C
(poly dT probe) overnight. For the hybridization
step, the hybridization bu#er was completed with
100 ng of the collagen probes, respectively 50 ng of
poly-dT probe, 50 ìl hybridization solution applied
of the specimen, covered with parafilm and incu-
bated in a humidified chamber overnight at 43)C
for the type VI collagen probes and 37)C for the
poly dT-probe. Sense-strand in-situ hybridization
was also performed with a Æ2(VI) or Æ3(VI) col-
lagen probe using the same conditions as for the
antisense hybridization.
After hybridization, the sections were washed
with 1#sodium chloride, sodium citrate (SSC) for
10 min at room temperature and with 0.3#SSC at
40)C for 1 h. Non-specifically bound riboprobes
were removed by RNase treatment, T1-RNase
194 O. Pullig et al.: Expression of type VI collagen in normal and osteoarthritic human cartilage25 U/ml combined with RNase A, 5 ìg/ml, in 5 mM
Tris, 0.5 M NaCl, pH 7.5, 5 mM EDTA for 1 h at
37)C. Sections were briefly washed in 1#SSC at
room temperature, stringently washed in 0.1#SSC
for 2 h at 45)C (riboprobes) or alternatively at 37)C
(oligoprobe) and finally washed in 0.5#SSC at
room temperature.
Detection of bound probes was performed using
a commercially available nucleic acid detection
kit (Boehringer Mannheim, Mannheim, Germany).
Briefly, sections were incubated in blocking
solution containing 10% (v/v) fetal calf serum.
After blocking, an anti-digoxigenin alkaline
phosphatase-labelled antibody was added and
bound antibodies were detected by adding the
substrate solution (X-phosphate/NBT) overnight.
Sections were counterstained with 0.5% (w/v) light
green (Merck, Darmstadt, Germany) in 5% (v/v)
ethanol and mounted in entellan (Merck,
Darmstadt, Germany).IMMUNOLOCALIZATION OF TYPE VI COLLAGEN
Tissue sections were de-para$nized in xylene
and rehydrated. The sections were then digested
with 2 mg/ml hyaluronidase (Merck, Darmstadt,
Germany) in PBS, pH 5.5 for 15 min at 37)C and
with 1 mg/ml pronase (Boehringer, Mannheim,
Germany) in PBS pH 7.4 for 30 min at 37)C. After
washing twice in PBS, sections were incubated in
5% (w/v) bovine serum albumin (BSA) bu#ered in
PBS. The polyclonal anti-human type VI collagen
antibody (lot no. 2A 0561 Telios Pharmaceuticals,
San Diego, CA, U.S.A) was diluted 1:100 in 1%(w/v) BSA/PBS and incubated overnight at 4)C.
After three washings in tris-bu#ered saline (TBS) a
biotin-labeled anti rabbit antibody from donkey
(Dianova, Hamburg, Germany) diluted 1:80 in 1%
(w/v) BSA/TBS was added for 30 min at room
temperature. Then, a complex of streptavidin and
biotin labelled with alkaline phosphatase was
added according to the protocol of the manufac-
turer (Dako, Hamburg, Germany). After three
short washes in TBS, bound antibodies were visu-
alized using Fast Red (Sigma, Mu¨nchen, Germany)
as a colour substrate. To exclude non-specific
background staining sections were incubated with
rabbit sera (Dako, Hamburg, Germany) and
immunohistochemical detection was followed as
described above.FIG. 1. Para$n sections of normal femoral knee cartilage (54-year old man, original magnifications (1a), (b): 30#, (c):
325#, T=tangential zone, M=middle zone, D=deep zone, C=calcified zone). (a). Safranin-0 staining shows a
homogenous staining in all cartilage layers with a reduction in the upper superficial layer, which is physiological.
(b, c) Staining for type VI collagen using a polyclonal antibody against type VI collagen as described in Material and
methods. Type VI collagen concentrates pericellularly around the chondrocytes in all cartilage zones. The inter-
territorial matrix of the middle layer also stains positive. (c) Higher magnification of the type VI collagen distribution
in the middle zones showing the pericellular staining.
FIG. 2. Para$n sections of a normal femoral knee cartilage (same sample as in Fig. 1), original magnifications 125#.
The upper part of the figures shows the tangential zone, middle part shows the middle zone, and lower part shows the
deep zone. (a) Expression of Æ2(VI) collagen mRNA was shown by in-situ hybridization using a digoxigenin-labelled
antisense riboprobe (see Material and methods). Chondrocytes from the tangential, middle and deep zones show
expression of Æ2(VI). (b) Negative control; section was incubated with the sense probe of type VI collagen. (c) In-situ
hybridization positive control to detect all polyadenylated mRNA. Hybridization was done using a 5*digoxigenin
labeled oligonucleotide specific for the poly-adenosine sites of mRNAs. All sections were counterstained with light
green to visualize the contours of matrix and cells.
FIG. 3. Para$n sections of femoral knee cartilage with moderate OA (71-year old woman, magnifications (a), (b): 30#,
(c): 325#, T=tangential zone, M=middle zone, D=deep zone, C=calcified zone). (a) Staining of the section with
Safranin-0 shows a depletion of proteoglycans in the superficial zone and fissures of the surface (b). Expression of the
type VI collagen molecule was visualized using a polyclonal antibody against type VI collagen as described under
Material and methods. Interterritorial staining is prominent in the middle zone and areas of the adjacent deep zone.
(c) Expression of type VI collagen protein in a higher magnification showing a section from the middle zone with a
pericellular and a strong interterritorial staining.STATISTICAL METHODS
Cartilage zone specific di#erences in (Æ2)VI
mRNA expression were determined by counting
the number of (Æ2)VI mRNA expressing cells in
relation to the number of cells showing a signal for
total mRNA. Samples from normal cartilage and
cartilage with minor lesions (N=10), moderate
lesions (N=10) and severe lesions (N=10) were
compared. All samples used by this statistical
analysis were from the central weight-bearing area
of the lateral femoral condyle. Chondrocytes
within a cartilage area of 1 mm in width were
counted. For statistical analysis, the percentages
of positive cells were compared in di#erent
stages of OA using a non-parametric statistic
(Mann-Whitney U-test).
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LOCALIZATION OF TYPE VI COLLAGEN IN NORMAL
CARTILAGE AND IN CARTILAGE WITH SLIGHT FIBRILLATIONS
OF THE ARTICULAR SURFACE
Normal articular cartilage was defined by an
intact smooth cartilage surface and an only faint
superficial reduction of the proteoglycans in the
safranin O staining, which is physiological [31]
[Fig. 1(a)].
No significant di#erences in the number of type
VI collagen expressing cells (Mann-Whitney-U
test) were found in normal cartilage and cartilage
with a slight fibrillation of the articular surface as
a minor osteoarthritic lesion. There were also no
di#erences in the distribution of type VI collagen
expression. Therefore, these two groups were
summarized.
Immunohistologically, chondrocytes of all
cartilage layers showed an intensive pericellular
staining for type VI collagen. In the subchondral
bone, also osteoblasts, osteocytes, yellow bone
marrow, and blood vessels stained positive for type
VI collagen [Fig. 1(b)]. The staining for type VI
collagen in the interterritorial cartilage matrix
was zone specific. An interterritorial staining
could not be observed in the superficial, lower
deep and calcified cartilage zone. However, in the
middle cartilage zone and in the adjacent areas of
the deep zone a di#use interterritorial distribution
of type VI collagen was observed [Fig. 1(b, c)]. No
type VI collagen could be detected in the terri-
torial matrix by immunostaining in all cartilageFIG. 4. (a) Expression of type VI collagen mRNA in the same sample as in Fig. 3 using a Æ2(VI) mRNA antisense probe,
(b) negative control with the Æ2(VI) mRNA sense probe, and (c) positive control using a probe specific for all
polyadenylated mRNAs in moderate OA. In-situ hybridization was carried out using digoxigenin labelled probes as
described in the Material and method section. Slides were counterstained with light green. Figures showing parts from
the tangential, middle and deep zone (from top to bottom), original magnification is 125#. (a) In-situ hybridization
using the Æ2(VI) probe shows increased mRNA expression in tangential, middle and deep cartilage layer compared
to normal cartilage. (b) Hybridization with the Æ2(VI) sense probe showed no unspecific hybridization of the probe.
(c) Positive control with a poly dT probe.
FIG. 5. Para$n sections of femoral knee cartilage with severe OA (67 year-old woman, magnifications (a), (b): 30#, (c):
325#, M=middle zone, D=deep zone, C=calcified zone). (a) Staining with Safranin-O shows a severe reduction of
proteoglycans down to the deep cartilage layer. Cartilage surface shows loss of superficial zone and deep fissures and
clusters of proliferating chondrocytes (see also Fig. 6, same sample). (b) Immunostaining of type VI collagen was done
as described under Material and methods. Note the territorial staining for type VI collagen around chondrocytes from
the deep zone. (c) Expression of type VI collagen protein in the deep zone in a higher magnification.
FIG. 6. Corresponding to Fig. 5 serial sections of severe OA were analyzed for (a) the expression of Æ2(VI) and (d) Æ3(VI)
mRNA. (b) A negative control and (c) a positive control showing all present mRNA are given. The upper part of the
figures represent former ‘middle-zone’, lower part represent deep and calcified zone as well the adjacent subchondral
bone. Original magnification is 125#. Sections were counterstained with light green. (a) Localization of Æ2(VI)
collagen mRNA is shown by in situ hybridization using a digoxigenin-labelled antisense riboprobe (see Material and
methods). ‘Clusters’ of chondrocytes show a strong signal for type VI collagen mRNA. (b) No specific staining is
observed using the Æ2(VI) sense probe (negative control). (c) In-situ hybridization with the poly dT probe shows
distribution of total mRNA in the chondrocytes. (d) Æ3(VI) mRNA probe shows staining in the ‘clusters’ and adjacent
cartilage layers.layers. Negative controls with rabbit serum
showed no staining in cartilage and bone (data not
shown). In-situ hybridization showed a specific
mRNA signal in chondrocytes of the superficial,
middle and deep zone, however the signal intensity
varied between cartilage zones. Whereas the
in-situ hybridization signal had the same intensity
in the middle and deep zones, the signal intensity
was reduced in the superficial zone [Fig. 2(a)].
Hybridization with the Æ3(VI) collagen probe
revealed no di#erences in this zone-specific expres-
sion (data not shown). The positive control probe
for polyadenylated RNAs showed staining in more
than 90% of the cells [Fig. 2(c)].
TYPE VI COLLAGEN EXPRESSION IN CARTILAGE WITH
MODERATE OSTEOARTHRITIC LESIONS
Cartilage specimens with moderate osteo-
arthritic lesions were defined by the fibrillation
of the articular surface with clefts down to the
middle zone. The Safranin O-staining for proteo-
glycans was markedly reduced [Fig. 3(a)]. The
pericellular staining pattern for the type VI colla-
gen molecule was similar to the data observed for
normal cartilage, however the staining intensity
was higher [Fig. 3(b, c)]. The most striking di#er-
ences could be observed in the middle cartilage
zone where the interterritorial matrix showed a
remarkable increase in the staining for type VI
collagen. The mRNA expression was most inten-
sive in the middle and deep cartilage layers
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of Æ2(VI) mRNA expressing cells varied enor-
mously between di#erent samples. The hybridiz-
ation signal of the control probe for the Æ3 chain
of type VI collagen corresponded to the signal
distribution of the Æ2(VI) probe.
TYPE VI COLLAGEN EXPRESSION IN SEVERE
OSTEOARTHRITIC CARTILAGE
Specimens with progressive matrix destruction
showed a loss of the superficial cartilage layers,
clefts down to the subchondral bone and the
formation of clusters of chondrocytes adjacent to
the clefts [Fig. 5(a)]. Chondrocytes of the remain-
ing middle and the deep zones showed the typical
pericellular staining. The staining intensity was
markedly enhanced compared to normal cartilage
or cartilage with minor lesions. Within the remain-
ing zones a territorial deposition of type VI col-
lagen was found [Fig. 5(b–c)]. In clusters of
chondrocytes a pericellular staining and a di#use
matrix staining was observed. Compared to the
pericellular distribution of type VI collagen in
normal or early OA the staining intensity was
increased. In in-situ hybridization, these cluster-
ing chondrocytes and chondrocytes from the deep
cartilage layer showed a strong signal for the type
VI collagen mRNA [Fig. 6(a)]. The number of cells
expressing type VI collagen mRNA was signifi-
cantly increased compared to cells from the middle
zone of less damaged cartilage (P<0.031) and to
cells from the deep zone of cartilage with minor
lesions (P<0.03) [Fig. 7]. Hybridization of two
samples with the Æ3 (VI) riboprobe also showed
prominent expression within the clusters of
chondrocytes and chondrocytes from the deep zone
[Fig. 6(d)].100
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FIG. 7. Distribution of Æ2(VI) mRNA expressing cells in
normal cartilage and cartilage with minor lesions
(N=10), moderate lesions (N=10), and severe lesions
(N=10). Number of chondrocytes showing expression of
the Æ2(VI) collagen mRNA were counted and set in
relation to the number of chondrocytes expressing total
mRNA (as revealed by the poly dT probe). Chondrocytes
of the superficial, middle, deep and calcified cartilage
zone were counted within an area of 1 mm in width. Bars
represent means with standard deviations.Discussion
To understand the mechanisms leading to the
breakdown of articular cartilage in OA, it is nec-
essary to have detailed information on the matrix
metabolism and on putative regulatory inter-
actions between the chondrocytes and the matrix
molecules and between the matrix molecules them-
selves. In the last decades, major matrix com-
ponents like type II collagen or aggrecan have
been investigated extensively. Recent studies also
focused on so called minor components of the
extracellular matrix like decorin, cartilage matrix
protein, cartilage oligomeric matrix protein, and
tenascin. This study systematically describes
the metabolic activation of type VI collagen in
osteoarthritic cartilage.Type VI collagen, a minor protein in cartilage
seems to play an important role for the integrity of
the cartilage matrix. Matrix interactions have
been demonstrated by in-vitro experiments [10, 14]
and cell-binding studies. [18–20, 32]. Therefore, a
probable physiological function of type VI col-
lagen is to anchor cells to their surrounding
matrix [21]. Type VI collagen may function as a
bridging molecule between the various com-
ponents of the extracellular matrix and the
chondrocyte surface.
In this investigation, the cartilage/bone samples
were divided into four groups: normal cartilage,
early-, moderate-, and servere osteoarthritic
lesions (Table 1). We used a grading system
initially described by Otte [29] that reflects the
progressive process of OA. For normal cartilage,
our results show a pericellular staining of type VI
collagen in all layers of human knee cartilage.
This pericellular staining is consistent with
ultrastructural and immunohistological data of
Poole et al. [21, 26] showing that type VI collagen
is localized next to the cell membrane. Investi-
gations on isolated chondrons in canine cartilage
showed dense aggregates of type VI collagen on
the outer margin of the pericellular capsule and
less compacted fibrils on the inner margin [26].
Earlier immunohistochemical studies using only
hyaluronidase treatment to unmask epitopes found
no or only a faint staining for type VI collagen
in the interterritorial matrix [27]). Using an
Osteoarthritis and Cartilage Vol. 7 No. 2 199Table I
Classification of osteoarthritic cartilage lesions (modified from Otte [29]). (N=number of samples)
N Surface Safranin-O staining Cluster formation
Normal cartilage 5 Smooth Homogenous, slight reduction in
the uppermost layer
Negative
Early lesions 10 Slight superficial fibrillations Reduction in the upper zone Negative
Moderate lesions 27 Deep fibrillations and clefts
down to the middle zone
Reduction down to the middle
zone
Positive
Servere lesions 35 Clefts down to the deep zone Reduction down to the deep zone Positiveadditional pronase digestion, normal cartilage
sections showed a more intensive and definitely
positive staining of the interterritorial matrix in
the middle and adjacent deep zone. Electronmicro-
scopically studies on postnatal human cartilage
also showed randomly arranged periodic fibrils
of type VI collagen in the interterritorial carti-
lage matrix without investigating zone-specific
distributions [25].
No type VI collagen was localized in the terri-
torial matrix of normal, slight, and moderate
a#ected cartilage samples. Type VI collagen has
been shown to be highly resistant against proteo-
lytic degradation mostly due to the high thermal
stability of the triple helical domain and the high
content of intramolecular disulphide bonds [7].
However, recent in-vitro studies indicate that ser-
ine proteinases, lysosomal enzymes, and the matrix
metalloproteinase-2 are able to degrade intact type
VI collagen [33–35]. A high proteolytic activity in
the territorial matrix might explain that this area
does not stain for type VI collagen.
Comparing the type VI collagen protein expres-
sion in normal articular cartilage and cartilage
with minor osteoarthritic lesions, there were no
notable di#erences. All cartilage zones showed a
pericellular staining for type VI collagen. In the
middle zone and in adjacent areas of the deep zone
an interterritorial distribution of type VI collagen
was detected. However, in cartilage samples with
moderate osteoarthritic lesions the interterritorial
staining for type VI collagen was strikingly
increased. These data are in accordance with
previous data on the type VI collagen content in
extracts of normal and osteoarthritic cartilage.
McDevitt et al. and Ronziere et al. described a
more intensive staining for type VI collagen in
Western blots of cartilage extracts from exper-
imentally induced canine OA and from human
osteoarthritic cartilage [28, 36]. A significantly
higher content of type VI collagen epitopes was
quantitated in osteoarthritic human knee carti-
lage using an ELISA assay [4]. These data, how-
ever, gave no information on the metabolic
activation of the chondrocytes. Therefore, wedeveloped an in-situ hybridization to investigate, if
the increased content of type VI collagen in carti-
lage extracts is caused by an enhanced synthesis of
type VI collagen or only the deposition of this
molecule in the extracellular matrix. We used a
310 bases antisense probe specific for the human
Æ2(VI) collagen mRNA. Screening of a human
sequence database led to a less then 54% sequence
homology to other known human proteins. In a
control hybridization using a Æ3(VI) specific ribo-
probe a similar distribution pattern was found as
for the Æ2(VI) probe, confirming the in-situ hybrid-
ization results for Æ2(VI) mRNA and suggesting
similar stimulatory mechanisms in OA. The
expression of type VI collagen mRNA was detect-
able in cells of the superficial, middle and deep
layer. However, in the superficial and deep zones,
only about 46% of the chondrocytes showed type
VI collagen expression whereas 58% of the middle
zone chondrocytes showed a positive type VI col-
lagen mRNA signal (Fig. 7). This may be explained
by a zone-specific higher turnover of type VI
collagen in the middle zone.
Comparing the in-situ hybridization data on
normal and moderate/severe osteoarthritic carti-
lage, we found an increased signal in osteoar-
thritic cartilage samples with an increased number
of positive cells. These data show that the pre-
viously described higher content of the type VI
collagen epitopes in cartilage extracts [4] may not
only be the result of a continuous deposition of
type VI collagen in the extracellular matrix, but is
likely to be also caused by an increased synthesis
of type VI collagen.
Basal levels of type VI collagen gene expression
are detectable in normal cartilage, suggesting,
that a continuous synthesis of the protein reflects
the physiological cell status. An increased syn-
thesis of type VI collagen in OA could be the result
of a specific response to an imbalanced matrix
composition as already discussed for other extra-
cellular matrix components [38–40]. We could
show that the immunostaining for type VI collagen
is increased in severe OA. This was observed for
the pericellular staining of all cartilage zones as
200 O. Pullig et al.: Expression of type VI collagen in normal and osteoarthritic human cartilagewell as for the interterritorial staining of the
middle and upper deep zone. In in-situ hybridiz-
ation, Æ2(VI) collagen mRNA was increased in
areas with an enhanced interterritorial staining.
Therefore, the interterritorial accumulation of
type VI collagen in OA is likely to be the result of
an enhanced synthesis of the protein. The high
proteolytic residence of type VI collagen may also
contribute to the enhanced matrix deposition seen
in moderate and servere osteoarthritic cartilage.
Since proteolytic enzymes are increased in osteo-
arthritic cartilage [41], a limited degradation of
the protein may occur and smaller fragments are
more likely to di#use into the interterritorial
matrix. This hypothesis is supported by biochemi-
cal analysis of type VI collagen from osteoarthritic
cartilage. Western blot analysis of guanidinium
extracts of osteoarthritic cartilage revealed
multiple shortened immunoreactive type VI
collagen fragments [28].
In cartilage with severe alterations of the extra-
cellular matrix, clusters of proliferating chondro-
cytes are observed. Chondrocytes of these clusters
showed the highest type VI collagen mRNA expres-
sion with more than 90% of positive cells. The
extracellular matrix surrounding these chondro-
cytes showed a di#use staining for type VI colla-
gen. Chondrocytes of these clusters are supposed
to represent a metabolically highly activated
phenotype. The high amount of newly synthesized
type VI collagen may also contribute to the pro-
liferation of chondrocytes in clusters. Recently, in
vitro studies have shown that soluble type VI
collagen is able to increase the proliferation of
mesenchymal cells [20]. Additionally to this poss-
ible autocrine pathway, traditional growth factors
and/or cytokines may influence the synthesis of
type VI collagen in OA. Clusters of chondrocytes
are often localized near fissures and clefts of the
upper cartilage layer. This shortens the di#usion
distance for nutrients as well as for cell mediators
from the synovial fluid. The influence of transform-
ing growth factor â (TGF-â) and interleukin-1
(IL-1) on type VI collagen synthesis has been inves-
tigated by in-vitro experiments. Increased syn-
thesis of type VI collagen was induced in dermal
fibroblasts by TGF-â [42] and in skin fibroblasts by
IL-1â [43]. In synovial fibroblasts of patients with
OA, IL-1Æ had the inverse e#ect on type VI colla-
gen. Cell culture experiments resulted in a
decrease of type VI collagen mRNA expression
dependent on IL-1Æ stimulation [44]. In vivo, how-
ever, chondrocytes are embedded in their extra-
cellular matrix and regulatory e#ects are likely to
be more complex.In OA, the biomechanical functions of the extra-
cellular matrix are mainly a#ected by the disrup-
tion of the collagen network and by the loss of
proteoglycans leading to a loss of the hydroelastic
properties of cartilage [45]. Changes in the meta-
bolic activity of chondrocytes, induced by mech-
anical impact have been investigated in in-vivo
and in-vitro models [46, 47]. The cascade of mech-
anotransduction involves proteins, which trans-
duce the extracellular mechanical signal into the
cellular compartment [48]. As mentioned before,
type VI collagen seems to be a link between carti-
lage matrix and the chondrocyte surface. It is
found in direct contact to the cell membrane,
interacts with cellular receptors and with various
matrix components. Higher levels of type VI colla-
gen in OA, as demonstrated in this study, may
influence the signalling pathways from the extra-
cellular matrix into the cells and contribute to an
altered metabolism in osteoarthritic cartilage.Acknowledgments
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